|
|
|
|
|
|
|
|
|
|
Rv0667 More about Rv0667 on TBDB.org More about Rv0667 on TubercuList |
Display all mutations or select a bar from the histogram above to examine in greater detail |
| Rv0667: Codons 525 to 549: 38 mutations (high confidence mutations are highlighted in yellow) | |||||||||||||||
| Primary reference | Polymorphism | Nucleotide position | Codon position | Amino acid | Time period | Origin | Molecular detection method | Gene coverage | Resistance pattern | MIC | Susceptibility testing method | R/Total isolates | R/S isolates with mutation | Additional mutations | High confidence support |
| Valim A JCM 2000 | ACC/CCC | - | 525 | Thr/Pro | 1996-1998 | Brazil | Sequencing | RRDR | MDR | N.S. | Proportion method | 82/100 | (1/0) | "Same isolate had changes in codons 524 TTG(Leu)/TGG(Trp); 526 CAC(His)/CTG(Leu); 527 del AAG(Lys)" | - |
| Pozzi G JCM 1999 | ACC/ATC | - | 525 | Thr/Ile | Published April 2001 | Italy | Sequencing | RRDR | RH, RHS, RHSCip, RHSAmi, RHSZ, RHSZAmi, RHSCZ | 8-128ug/ml | Proportion method | 37/37 | (1/0) | Triple mutation with GAC516TAC and GGG523TGG | - |
| Bahrmand AR JCM 2009 | CAC/TTC | - | 526 | His/Phe | 2005-2006 | Iran | Sequencing | 411bp fragment of rpoB | 41R, 37MDR | >100 ug/ml | Proportion method | 41/286 | 2/0 | rpoB S512T, G513N, S531L | - |
| Ramaswamy SV J Med Micro 2004 | CAC/AAC | - | 526 | His/Asn | 1996-2001 | Mexico | Sequencing | - | RHSE | N.S. | Proportion method | 37/50 | (1/0) | "rpoB: Double mutation with 435 GAC/GAG; embB: 306 ATG/ATA1 " | ![]() |
| Kapur V JCM 1994 | CAC/GAC | - | 526 | His/Asp | Published 1994 | USA | Sequencing | Whole gene | R | N.S. | Proportion method, BACTEC | 121/128 | 8/0 | None described in the region sequenced. | ![]() |
| Kapur V JCM 1994 | CAC/TAC | - | 526 | His/Tyr | Published 1994 | USA | Sequencing | Whole gene | R | N.S. | Proportion method, BACTEC | 121/128 | 39/0 | None described in the region sequenced. | ![]() |
| Secondary Publication: Ramaswamy S Musser JM Tubercle lung Dis 1998 | CAC/ACC | - | 526 | His/Thr | - | - | - | - | - | - | - | - | - | - | - |
| Prammananan T CMI 2008 | CAC/AGC | - | 526 | His/Ser | 2003-2005 | Thailand | Sequencing | Whole gene | MDR | N.S. | Proportion method | 154/113 | 1/0 | rpoB 515 ATG/CTG | - |
| Secondary Publication: Ramaswamy S Musser JM Tubercle lung Dis 1998 | CAC/GGC | - | 526 | His/Gly | - | - | - | - | - | - | - | - | - | - | - |
| Kim BJ JCM 1997 | CAC/TGC | - | 526 | His/Cys | Published 1997 | South Korea | PCR-SSCP, Sequencing | RRDR | R | N.S. | Absolute concentration method. | 32/58 | 2/0 | Location of double mutants not specified. | - |
| Kim BJ JCM 1997 | CAC/CGC | - | 526 | His/Arg | Published 1997 | South Korea | PCR-SSCP, Sequencing | RRDR | R | N.S. | Absolute concentration method. | 32/58 | 1/0 | Location of double mutants not specified. | ![]() |
| Bodmer T JAC 1995 | CAC/CCC | - | 526 | His/Pro | Published 2001 | N.S. | PCR-SSCP | RRDR | R | 8ug/ml | BACTEC 460 | 26/36 | (2/0) | - | - |
| Valim A JCM 2000 | CAC/CTG | - | 526 | His/Leu | 1996-1998 | Brazil | Sequencing | RRDR | RHSEZEth | N.S. | Proportion method | 82/100 | (1/0) | "Same isolate had changes in codons 524 TTG(Leu)/TGG(Trp); 525 ACC(Thr)/CCC(Pro); 527 del AAG(Lys)" | - |
| Sheng J JApplMicro 2008 | CAC/CTT | - | 526 | His/Leu | 2002-2003 | China | PCR-SSCP , Sequencing | RRDR | R | N.S. | Agar proportion method | 49/56 | 1/0 | None in rpoB | - |
| Kapur V JCM 1994 | CAC/CTC | - | 526 | His/Leu | Published 1994 | USA | Sequencing | Whole gene | R | N.S. | Proportion method, BACTEC | 121/128 | 2/0 | None described in the region sequenced. | ![]() |
| Kapur V JCM 1994 | CAC/CAA | - | 526 | His/Gln | Published 1994 | USA | Sequencing | Whole gene | R | N.S. | Proportion method, BACTEC | 121/128 | 1/0 | Also mutated at Ser456Cys. | - |
| Bodmer T JAC 1995 | CAC/CAG | - | 526 | His/Gln | Published 2003 | N.S. | PCR-SSCP | RRDR | R | >8ug/ml | BACTEC 460 | 26/36 | (2/0) | Double mutation with 498 Val/Ala | - |
| Siddiqi N AAC 2002 | AAG/AAT | - | 527 | Lys/Asn | 1995-1998 | India | Sequencing | RRDR | HRH | 40 ug/ml | Proportion method | 94/126 | (2/0) | "1) katG or inhA R463L; 2) katG or inhA R463L, rpoB dual mutation with L521L" | - |
| Valim A JCM 2000 | del AAG | - | 527 | del Lys | 1996-1998 | Brazil | Sequencing | RRDR | RHSEZEth | N.S. | Proportion method | 82/100 | (1/0) | "Same isolate had changes in codons 524 TTG(Leu)/TGG(Trp); 525 ACC(Thr)/CCC(Pro); 526 CAC(His)/CTG(Leu)" | - |
| Williams D AAC 1994 | AAG/CAG | - | 527 | Lys/Gln | Published 1995 | USA | PCR-HDF, Sequencing | RRDR | RHEEt | N.S. | Proportion method | 108/120 | (1/0) | Double mutation with 526 (His) | - |
| Siddiqi N AAC 2002 | CGC/CAC | - | 528 | Arg/His | 1995-1998 | India | Sequencing | RRDR | HR, ROS | 64-128 ug/ml | Proportion method | 94/126 | (2/0) | "1) rpoB dual mutation with H526Y; gyrA S95T; rpsL NM; 2) rpoB 1 dual mutation with with S531W; katG and inhA R463L, Inh (C/T)" | - |
| Siddiqi N AAC 2002 | CGC/CCC | - | 528 | Arg/Pro | 1995-1998 | India | Sequencing | RRDR | ROS, RHO, RHS, RH | 40-64 ug/ml* | Proportion method | 94/126 | (4/0) | "1) rpoB dual mutation with N518T; gyrA S95T; rpsL NM; 2) katG or inhA NA; gyrA S95T; 3) katG or inhA R463L; rpsL K121K; 4) katG or inhA R463L; rpoB dual mutation with H526Y" | - |
| Zenteno-Cuevas R MemInstOswaldCruz 2009 | CGC/CCT | - | 528 | Arg/Pro | 2007 | Mexico | Sequencing | RRDR | HRSEZ | N.S. | BACTEC 460 | 15/25 | 1/0 | None | - |
| Wang Q JProtRes 2007 | TCG/TAG | - | 538 | Leu/STOP | Published 1997 | China | Sequencing | Whole gene | R | N.S. | Proportion method, absolute concentration method | 112/30 | 1/0 | - | - |
| Secondary Publication: Ramaswamy S Musser JM Tubercle lung Dis 1998 | TCG/CAG | - | 531 | Ser/Gln | - | - | - | - | - | - | - | - | - | - | - |
| Donabella V Am J Respir Cell Mol Biol 1994 | TCG/TTG | - | 531 | Ser/Leu | Published 1994 | USA | Sequencing | RRDR | R | N.S. | - | (1/9) | (1/0) | - | ![]() |
| Bodmer T JAC 1995 | TCG/TGG | - | 531 | Ser/Trp | Published 2005 | N.S. | PCR-SSCP | RRDR | R | 8ug/ml | BACTEC 460 | 26/36 | (1/0) | - | ![]() |
| Bodmer T JAC 1995 | TCG/TAT | - | 531 | Ser/Tyr | Published 2006 | N.S. | PCR-SSCP | RRDR | R | >8ug/ml | BACTEC 460 | 26/36 | (1/0) | - | - |
| Hillemann D AAC 2005 | TCG/TTT | - | 531 | Ser/Phe | 2001 | Germany | real-time sequencing | RRDR | MDR | N.S. | - | 103/113 | (2/0) | katG 315 AGC-ACC/Ser-Thr | - |
| Secondary Publication: Ramaswamy S Musser JM Tubercle lung Dis 1998 | TCG/TGT | - | 531 | Ser/Cys | - | - | - | - | - | - | - | - | - | - | - |
| Moghazeh SL AAC 1996 | CTG/CCG | - | 533 | Leu/Pro | 1992-1995 | USA | Sequencing | N.S | R | >32ug/ml | Proportion method | 24/24 | 1/0 | None described in the region sequenced. | ![]() |
| Valim A JCM 2000 | CTG/CCT | - | 533 | Leu/Pro | 1996-1998 | Brazil | Sequencing | RRDR | RH, RHS | N.S. | Proportion method | 82/100 | (2/0) | Same isolate had double mutation: 526 CAC(His)/CTG(Leu) | - |
| Tracevska T JCM 2002 | CCC/TCC | - | 535 | Pro/Ser | 1999-2000 | Latvia | Line probe assay, Sequencing | RRDR | R, RH | N.S. | Absolute concentration method, BACTEC | 51/70 | (4/0) | Double mutation with D516Y | - |
| Prammananan T CMI 2008 | CCC/CAC | - | 535 | Pro/His | 2003-2005 | Thailand | Sequencing | Whole gene | MDR | N.S. | Proportion method | 154/113 | 1/0 | rpoB 526 CAC/AGC His/Ser | - |
| Wang Q JProtRes 2007 | CTG/CCG | - | 538 | Leu/Pro | Published 1997 | China | Sequencing | Whole gene | R | N.S. | Proportion method, absolute concentration method | 112/30 | 1/0 | - | - |
| Prammananan T CMI 2008 | GAG/GGG | - | 541 | Glu/Gly | 2003-2005 | Thailand | Sequencing | Whole gene | MDR | N.S. | Proportion method | 154/113 | 1/0 | rpoB 526 CAC/TAC His/Tyr | - |
| Pozzi G JCM 1999 | GAG/GAT | - | 541 | Glu/Gly | Published 2002 | Italy | Sequencing | RRDR | RH, RHS, RHSCip, RHSAmi, RHSZ, RHSZAmi, RHSCZ | 32-128 ug/ml | Proportion method | 37/37 | (1/0) | Triple mutation with CAC526GAC and TCG553GCG | - |
| Aslan G JpnJInfectDis 2008 | CTG/ATG | - | 545 | Leu/Met | 2003-2006 | Turkey | Sequencing | RRDR | R or MDR | N.S. | BACTEC 460 | 19/41 | 3/0 | rpoB S531A, katG S315T | - |
rpoB disclaimer: All mutation coordinates are in reference to E. coli and not M. tuberculosis. |
|||||||||||||||
Disclaimer: These are all putative mutations found in drug resistant clinical TB isolates. No a priori decisions have been made as to whether these mutations are causally related to resistance or possible secondary mutations. |
|
© 2010 Andreas Sandgren | Supported by the Swedish Research Council | Contact Database Curator |